Results 221 to 230 of about 229,255 (286)
Uric acid mediates the association of alpha-1 acid glycoprotein with gallstones in adult women in the United States. [PDF]
Liu X+6 more
europepmc +1 more source
ABSTRACT Background The prevalence of high body mass index (BMI) contributes to an increased risk of various diseases. This study aimed to identify global disease burden trends associated with high BMI from 1990 to 2019 and forecasts up to 2040. Methods Using data from the global burden of disease (GBD) 2019 study, we analysed the number and ratio of ...
Eun‐Ji Kim+4 more
wiley +1 more source
Innovative modeling: a diet-induced quail model for progressive pathological changes in uric acid metabolism disorders. [PDF]
Xu Y+8 more
europepmc +1 more source
Gout in pregnancy: Obstetric and neonatal outcomes
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar+3 more
wiley +1 more source
Isoliquiritigenin Promotes the Repair of High Uric Acid-Induced Vascular Injuries. [PDF]
Zhou H+7 more
europepmc +1 more source
THE RÔLE OF THE DIGESTIVE GLANDS IN THE EXCRETION OF ENDOGENOUS URIC ACID
Lafayette B. Mendel, R. L. Stehle
openalex +1 more source
Abstract Objective To evaluate the diagnostic and prognostic significance of maternal serum thrombospondin‐4 (TSP‐4) levels in pre‐eclampsia (PE), including comparisons between early‐ and late‐onset disease and between mild and severe cases, and to examine associations with adverse perinatal outcomes. Methods A prospective study was conducted including
Ruken Dayanan+2 more
wiley +1 more source
ABSTRACT Introduction Enfortumab vedotin plus pembrolizumab (EV + P) shows high efficacy in metastatic urothelial carcinoma (mUC), potentially increasing tumor lysis syndrome (TLS) risk. Case Presentation A 64‐year‐old man with mUC underwent surgery and adjuvant nivolumab after neoadjuvant chemotherapy.
Daigo Takemori+15 more
wiley +1 more source